Zobrazeno 1 - 10
of 981
pro vyhledávání: '"O, Pfaar"'
Autor:
O. Pfaar, P. Zieglmayer
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-9 (2020)
Abstract Allergen exposure chambers (AECs) have been developed for controlled allergen challenges of allergic patients mimicking natural exposure. As such, these facilities have been utilized e.g., for proof of concept, dose finding or the demonstrat
Externí odkaz:
https://doaj.org/article/abbb948e1703421aad17d6d237302403
Autor:
V. Mahler, D. Mentzer, A. Bonertz, A. Muraro, P. Eigenmann, J. Bousquet, S. Halken, O. Pfaar, M. Jutel, U. Wahn, S. Vieths, S. Kaul
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-7 (2020)
Abstract Concerning development of medicinal products, children belong to a so-called “special population” for which additional legislation applies: Regulation (EC) No 1901/2006 on medicinal products for paediatric use sets up a system of require
Externí odkaz:
https://doaj.org/article/a7b64716ac414b3392b67317faac2d9c
Publikováno v:
Clinical and Translational Allergy, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Allergen immunotherapy (AIT) is the only treatment option available for allergic patients with disease-modifying intention. Both efficacy and safety has been demonstrated for multiple trials in children, adolescents and adults. Though regula
Externí odkaz:
https://doaj.org/article/0aa8edfda5634e9d8de6cfa166f7a8e4
Autor:
I. Agache, I. Annesi-Maesano, A. Bonertz, F. Branca, A. Cant, Z. Fras, F. Ingenrieth, L. Namazova-Baranova, M. Odemyr, A. Spanevello, S. Vieths, A. Yorgancioglu, M. Alvaro-Lozano, D. Barber Hernandez, T. Chivato, S. Del Giacco, Z. Diamant, I. Eguiluz-Gracia, R. G. van Wijk, P. Gevaert, A. Graessel, P. Hellings, K. Hoffmann-Sommergruber, M. Jutel, S. Lau, A. Lauerma, J. Maria Olaguibel, L. O’Mahony, C. Ozdemir, O. Palomares, O. Pfaar, J. Sastre, G. Scadding, C. Schmidt-Weber, P. Schmid-Grendelmeier, M. Shamji, I. Skypala, M. Spinola, O. Spranger, M. Torres, A. Vereda, S. Bonini
Publikováno v:
Педиатрическая фармакология, Vol 16, Iss 5, Pp 281-295 (2020)
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision‐makers in the field of allergy,
Externí odkaz:
https://doaj.org/article/b15666add1f64a81aa5f0201b863f2e3
Autor:
C. Pitsios, M. Tsoumani, M. B. Bilò, G. J. Sturm, P. Rodríguez del Río, R. Gawlik, F. Ruëff, G. Paraskevopoulos, E. Valovirta, O. Pfaar, M. A. Calderón, P. Demoly
Publikováno v:
Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background Recommendations on contraindications to allergen immunotherapy (AIT) have been independently developed by National and International Societies/Academies. AIT contraindications are mainly based on case reports, case-series, or expe
Externí odkaz:
https://doaj.org/article/5d29e65960a24aeeba63438963cf104f
Autor:
J. Bousquet, A. Bedbrook, W. Czarlewski, G. L. Onorato, S. Arnavielhe, D. Laune, E. Mathieu-Dupas, J. Fonseca, E. Costa, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, M. Illario, E. Menditto, G. W. Canonica, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, W. J. Fokkens, N. H. Chavannes, S. Reitsma, A. A. Cruz, J. da Silva, F. S. Serpa, D. Larenas-Linnemann, J. M. Fuentes Perez, Y. R. Huerta-Villalobos, D. Rivero-Yeverino, E. Rodriguez-Zagal, A. Valiulis, R. Dubakiene, R. Emuzyte, V. Kvedariene, I. Annesi-Maesano, H. Blain, P. Bonniaud, I. Bosse, Y. Dauvilliers, P. Devillier, J. F. Fontaine, J. L. Pépin, N. Pham-Thi, F. Portejoie, R. Picard, N. Roche, C. Rolland, P. Schmidt-Grendelmeier, P. Kuna, B. Samolinski, J. M. Anto, V. Cardona, J. Mullol, H. Pinnock, D. Ryan, A. Sheikh, S. Walker, S. Williams, S. Becker, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-Wirnsberger, P. V. Tomazic, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, T. Vasankari, B. Gemicioğlu, A. Yorgancioglu, N. G. Papadopoulos, E. P. Prokopakis, I. G. Tsiligianni, S. Bosnic-Anticevich, R. O’Hehir, J. C. Ivancevich, H. Neffen, M. E. Zernotti, I. Kull, E. Melén, M. Wickman, C. Bachert, P. W. Hellings, G. Brusselle, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, L. P. Boulet, J. Bouchard, D. K. Chu, H. J. Schünemann, M. Sova, G. De Vries, M. van Eerd, I. Agache, I. J. Ansotegui, M. Bewick, T. Casale, M. Dykewick, M. Ebisawa, R. Murray, R. Naclerio, Y. Okamoto, D. V. Wallace, The MASK study group
Publikováno v:
Clinical and Translational Allergy, Vol 9, Iss 1, Pp 1-19 (2019)
Abstract Aims Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life c
Externí odkaz:
https://doaj.org/article/387d2bfd7cb34c438e5aa80cf56def7a
Publikováno v:
Allergologie. 46:184-192
Publikováno v:
Allergologie. 46:193-203
Autor:
L. Klimek, U. Förster-Ruhrmann, H. Olze, A. G. Beule, A. M. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, S. Strieth, H. Wrede, W. Schlenter, H. J. Welkoborsky, B. Wollenberg, S. Becker, F. Bärhold, F. Klimek, I. Casper, J. Zuberbier, C. Rudack, M. Cuevas, C. A. Hintschich, O. Guntinas-Lichius, T. Stöver, C. Bergmann, P. Werminghaus, O. Pfaar, J. Gosepath, M. Gröger, C. Beutner, M. Laudien, R. K. Weber, T. Hildenbrand, A. S. Hoffmann, C. Bachert
Publikováno v:
Laryngo-Rhino-Otologie. 102:89-99
Zusammenfassung Hintergrund Die chronische Rhinosinusitis mit Nasenpolypen (CRSwNP) ist eine multifaktorielle entzündliche Erkrankung der Schleimhäute von Nase und Nasennebenhöhlen. Eine eosinophile Entzündung wird als häufiger Endotyp beschrieb
Autor:
J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, G. L. Onorato, J. L. Pépin, R. Picard, F. Portejoie, E. Costa, J. Fonseca, O. Lourenço, M. Morais-Almeida, A. Todo-Bom, A. A. Cruz, J. da Silva, F. S. Serpa, M. Illario, E. Menditto, L. Cecchi, R. Monti, L. Napoli, M. T. Ventura, G. De Feo, D. Larenas-Linnemann, M. Fuentes Perez, Y. R. Huerta Villabolos, D. Rivero-Yeverino, E. Rodriguez-Zagal, F. Amat, I. Annesi-Maesano, I. Bosse, P. Demoly, P. Devillier, J. F. Fontaine, J. Just, T. P. Kuna, B. Samolinski, A. Valiulis, R. Emuzyte, V. Kvedariene, D. Ryan, A. Sheikh, P. Schmidt-Grendelmeier, L. Klimek, O. Pfaar, K. C. Bergmann, R. Mösges, T. Zuberbier, R. E. Roller-Wirnsberger, P. Tomazic, W. J. Fokkens, N. H. Chavannes, S. Reitsma, J. M. Anto, V. Cardona, T. Dedeu, J. Mullol, T. Haahtela, J. Salimäki, S. Toppila-Salmi, E. Valovirta, B. Gemicioğlu, A. Yorgancioglu, N. Papadopoulos, E. P. Prokopakis, S. Bosnic-Anticevich, R. O’Hehir, J. C. Ivancevich, H. Neffen, E. Zernotti, I. Kull, E. Melen, M. Wickman, C. Bachert, P. Hellings, S. Palkonen, C. Bindslev-Jensen, E. Eller, S. Waserman, M. Sova, G. De Vries, M. van Eerd, I. Agache, T. Casale, M. Dykewickz, R. N. Naclerio, Y. Okamoto, D. V. Wallace, MASK study group
Publikováno v:
Clinical and Translational Allergy, Vol 8, Iss 1, Pp 1-21 (2018)
Abstract mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching th
Externí odkaz:
https://doaj.org/article/0a9a93c71ddf464189aa653c1d6ab3c9